Skip to main content

Table 1 Demographics, site of disease, strain family and drug resistance profile in new patients with culture–confirmed tuberculosis diagnosed in New South Wales, Australia

From: Temporal dynamics of Mycobacterium tuberculosis genotypes in New South Wales, Australia

Category

Year

Total

2010

2011

2012

n (%)

Gender

    

   Male

219 (61.3)

219 (59.0)

188 (53.6)

626 (58.0)

Age group

    

   <15 years

4 (1.1)

5 (1.3)

6 (1.7)

15 (1.4)

   15-29 years

99 (27.7)

94 (25.3)

102 (29.1)

295 (27.3)

   30-44 years

110 (30.8)

116 (31.3)

102 (29.1)

328 (30.4)

   45-59 years

63 (17.6)

60 (16.2)

48 (13.7)

171 (15.8)

   ≥60 years

81 (22.7)

96 (25.9)

93 (26.5)

270 (25.0)

Site of disease

    

   Respiratory

258 (72.3)

260 (70.1)

241 (68.7)

759 (70.3)

   Non-respiratory

99 (27.7)

111 (29.9)

110 (31.3)

320 (29.7)

Strain family

    

   Beijing

93 (26.1)

108 (29.1)

97 (27.6)

298 (27.6)

   East African Indian

112 (31.4)

101 (27.2)

95 (27.1)

308 (28.5)

   Delhi/CAS

47 (13.2)

53 (14.3)

49 (14.0)

149 (13.8)

   LAM

25 (7.0)

14 (3.8)

22 (6.3)

61 (5.7)

   Haarlem

13 (3.6)

21 (5.7)

24 (6.8)

58 (5.4)

   Other

67 (18.8)

74 (19.9)

64 (18.2)

205 (19.0)

Drug resistance

    

   Isoniazid mono-resistance

21 (5.9)

23 (6.2)

29 (8.3)

73 (6.8)

   Multi- or extremely drug resistant (M/XDR)

7 (2.0)

6 (1.6)

5 (1.4)

18 (1.7)

Total

357 (100)

371 (100)

351 (100)

1079 (100)